This presentation describes the updates to the recently published 2025 treatment guidelines for Hepatitis B (HBV). It will define goals of therapy when treating individuals with chronic HBV and outline management strategies for the various phases of infection, including the indeterminant phase. Updated recommendations concerning treating HBV in pregnancy, those in high-risk scenarios, and the immune tolerant phase will be reviewed. The latest guidance on treatment discontinuation and surveillance for hepatocellular carcinoma will be discussed. This presentation provides background to and will enhance understanding of the updated guidelines, emphasizing the application of disease monitoring and shared decision making in treating patients with chronic HBV infection.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Top 6 courses
-

-

-

-

-

-
Guideline Update: PSVD-NCPF Nomenclature0.5 Credits
Specialties served/covered
- Adolescent Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Interventional Radiology
- Medical Oncology
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Transplant Hepatology
- Radiation Oncology
- Surgical Oncology
- Transplant Hepatology
- Cross-Specialty
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- No reviews yet. Be the first to share yours.


